Brawn Biotech (530207.BO) Stock Price

Brawn Biotech Price

CLOSED
25.40
​
Market closed

Revenue at Brawn Biotech has contracted by 22.2% per year over the past 2 years to 134.65 M INR. For Brawn Biotech, the net margin of -12.9% is down versus -3.9% a few years ago.

Brawn Biotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Brawn Biotech business model & stock analysis

Brawn Biotech Ltd. engages in the manufacture, contracting, and supply of pharmaceutical and medical products. The company is headquartered in New Delhi, Delhi. The firm's pharmaceutical products cover all product segments, antibacterials, cardiovasculars, antidiabetics, analgesics, gastrointestinals, antifungals, skin care, antipsychotics, Antiasthmatics, Antacids, Antimalarials, and Nutritionals. Its products include Sefix-400 Capsules, Sefix-200 Capsules, Celevran Cream W/C (25GM), Voltran Gel W/C (25GM), Folic Acid Tablets 8P 5MG, Ponstran Capsules 250MG, Fugeran Cream W/C (15GM), Stopin Tablets, Cefixime Tablets 100MG (1*10), Cefixime Tablets USP 200MG (1*10), Carbramazepine 200 MG IP Tab, Potassium Chloride for Injection 15% 150mg/ml USP (10 ML), Promethazine HCL Injection 25 MG/ML, Allopurinol 100mg IP Tab, Carbamazepine 100 mg IP Tab Feme Tab, Bromex Liquid, Salbutamol 4 mg IP Tab, Chlorpheniramine Maleate 4mg Tab, Pheniramine Maleate 25mg Tab, Eracef 500 mg, Erazide 1 Gm Injection, Hyoscine Butyl Bromide (1 ml) IP Inj and Alprazolam 0.5 Mg Tab.

Frequently asked questions about Brawn Biotech

Converted at the current exchange rate, the Brawn Biotech share trades at 0.24 EUR (25.40 INR).

The revenue cannot currently be calculated for Brawn Biotech.

The profit cannot currently be calculated for Brawn Biotech.

The P/E ratio cannot be calculated for Brawn Biotech at the moment.

The P/S cannot be calculated for Brawn Biotech currently.

The Eulerpool Quality Score for Brawn Biotech is 2/10.

The ISIN of Brawn Biotech is INE899B01015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Brawn Biotech is 530207.BO. The ticker symbol is used to trade Brawn Biotech shares on the stock exchange.

Fair ValueTerminal
25.40 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Mar 6, 1995
ISIN
INE899B01015
Cusip
Y0968Y116
Market capitalization
76.20 M INRMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.27
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-51.75 %
Last updated Oct 20, 2026, 2:47 PM

Brawn Biotech Peer Group